] As of Dec. 14 02:10 P.M., Kyongbo Pharmaceutical declined 1.56%, compared with yesterday, to 12,600 won. It had declined 9.35% through the past month. Standard deviation, the volatility index for stock price, was 1.4% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, even though the monthly earnings rate of Kyongbo Pharmaceutical stayed negative, its volatility for 1 month was at the lowest level. Over the recent month, the Return On Risk, the return on investment with consideration about risk, was -6.6%. Though the volatility was the lowest among its peer group, the Return On Risk was low as stock price decline. Moreover, compared with the KOSPI industry, the Return On Risk is below the industrial mean, -0.4, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (firstname.lastname@example.org
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp